Skip to content

Sildenafil versus Papaverine in the diagnosis of male erectile dysfunction

Sildenafil as an alternative to Papaverine for the diagnostic evaluation of erectile dysfunction (ED) with penile doppler ultrasonography (PDUS)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/08/006096
Enrollment
60
Registered
2015-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Erectile Dysfunction Health Condition 2: N529- Male erectile dysfunction, unspecified

Interventions

Intervention1: S-Group: One Tablet of Sildenafil Citrate 100mg administered with a glass of water about one hour prior to penile doppler ultrasonography in patients of ED. Control Intervention1: P-Gro

Sponsors

University College of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 All patients aged greater than or equal to 18 years giving informed consent to participate in the study. 2 At least a 3 months prior history of erectile dysfunction. 3 International Index of Erectile Function-5 (IIEF-5)13 scores

Exclusion criteria

Exclusion criteria: 1. Patients not willing for consent for inclusion in the above study. 2. Patients on Sildenafil citrate therapy within last two weeks. 3.Patients with known contraindications for PDE5-Is such as poor cardiac performance, severe ischemia, coagulation defects, recent myocardial infarction and patients on nitrate therapy.

Design outcomes

Primary

MeasureTime frame
PSV above 30cms-1 EDV below 5cms-1 and or RI below 0.8 for penile arterial insufficiency. EDV above 5cms (or RI below 0.8) for penile venogenic dysfunction. Clinical erection hardness score (E1-E4)for ED in general.Timepoint: 5,10,15,20,25,30,35,40,45 minutes.

Secondary

MeasureTime frame
NoneTimepoint: None

Countries

India

Contacts

Public ContactDr Amit Kumar

Dept of Surgery OPD

dramitkr12@gmail.com22586262

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026